CN114105921A - Cyclopentyl benzofuran liquid crystal compound and application thereof - Google Patents

Cyclopentyl benzofuran liquid crystal compound and application thereof Download PDF

Info

Publication number
CN114105921A
CN114105921A CN202111583041.4A CN202111583041A CN114105921A CN 114105921 A CN114105921 A CN 114105921A CN 202111583041 A CN202111583041 A CN 202111583041A CN 114105921 A CN114105921 A CN 114105921A
Authority
CN
China
Prior art keywords
liquid crystal
compound
reaction
alkali
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111583041.4A
Other languages
Chinese (zh)
Other versions
CN114105921B (en
Inventor
石志亮
李小赢
杨凯
杭德余
呼建军
程丹丹
班全志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Yunji Technology Co Ltd
Original Assignee
Beijing Yunji Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Yunji Technology Co Ltd filed Critical Beijing Yunji Technology Co Ltd
Priority to CN202111583041.4A priority Critical patent/CN114105921B/en
Publication of CN114105921A publication Critical patent/CN114105921A/en
Application granted granted Critical
Publication of CN114105921B publication Critical patent/CN114105921B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • C09K19/44Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing compounds with benzene rings directly linked
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/0403Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems
    • C09K2019/0407Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems containing a carbocyclic ring, e.g. dicyano-benzene, chlorofluoro-benzene or cyclohexanone
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/0403Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems
    • C09K2019/0414Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems containing a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention relates to the technical field of liquid crystal compounds, in particular to a novel cyclopentyl benzofuran liquid crystal compound and application thereof. The liquid crystal compound provided by the invention has a structure shown in a general formula (I), has high negative dielectric anisotropy, good liquid crystal intersolubility and relatively low rotational viscosity, can improve the performance of a liquid crystal material, and has important application value.

Description

Cyclopentyl benzofuran liquid crystal compound and application thereof
Technical Field
The invention relates to the technical field of liquid crystal compounds, in particular to a novel cyclopentyl benzofuran liquid crystal compound and application thereof.
Background
In recent years, liquid crystal display devices have been developed more and more rapidly, and various types of liquid crystal display devices have appeared, such as small-sized liquid crystal display devices for vehicles, portable liquid crystal display devices, ultra-thin liquid crystal display devices, and the like. The development in the art is progressing, taking liquid crystal display as an example, which is characterized by light weight, small occupied space, and convenience in movement, as well as notebook-type personal computers, palm computers, mobile phones, and the like.
The liquid crystal material has great research value and good application prospect in the fields of information display materials, organic optoelectronic materials and the like. At present, the TFT-LCD product technology has matured, and successfully solves the technical problems of viewing angle, resolution, color saturation, brightness, etc., and large-size and medium-and small-size TFT-LCD displays have gradually occupied the mainstream status of flat panel displays in respective fields. Meanwhile, the requirements for display technologies are continuously increasing, for example, a liquid crystal display is required to achieve faster response, and a driving voltage is reduced to reduce power consumption, so that a liquid crystal material is required to have low-voltage driving, fast response, a wide temperature range, good low-temperature stability, and other properties.
The liquid crystal material plays an important role in improving the performance of the liquid crystal display, and particularly, the performance of the liquid crystal display can be obviously improved by reducing the rotational viscosity of the liquid crystal material and improving the dielectric anisotropy delta epsilon of the liquid crystal material. Therefore, in order to improve the properties of liquid crystal materials to meet new requirements, the synthesis of liquid crystal compounds with novel structures and the study of the structure-property relationship have become an important work in the liquid crystal field.
Disclosure of Invention
The invention aims to develop a novel cyclopentyl benzofuran liquid crystal compound, in particular a fluorine-containing benzofuran liquid crystal compound which has higher negative dielectric anisotropy, good liquid crystal intersolubility, relatively low rotational viscosity and the like, can improve the performance of a liquid crystal material, and has important application value.
In a first aspect, the present invention provides a liquid crystal compound of cyclopentyl benzofuran, which has a structure shown as general formula (I):
Figure BDA0003426766150000021
wherein R represents an alkyl group, an alkoxy group or an alkenyl group having 1 to 12 carbon atoms;
A1、A2independently of one another, 1, 4-phenylene, 1, 4-cyclohexylene, 1, 4-cyclohexenylene or fluoro-1, 4-phenylene;
Z1、Z2independently of each other, represents a single bond, a double bond, an oxygen atom, -CF2O-、-CH2CH2-、-CH2O-、-OCH2-or-CH ═ CH-;
m and n independently represent 0, 1 or 2.
Wherein the fluoro 1, 4-phenylene is mono-fluoro 1, 4-phenylene, difluoro 1, 4-phenylene, trifluoro 1, 4-phenylene or tetrafluoro 1, 4-phenylene; preferably, the fluoro 1, 4-phenylene is mono-fluoro 1, 4-phenylene or di-fluoro 1, 4-phenylene.
As a preferred embodiment of the present invention, in the general formula (I), m and n independently represent 0 or 1.
As a preferred embodiment of the present invention, R represents an alkyl group, an alkoxy group or an alkenyl group having 1 to 5 carbon atoms.
Further preferably, said R represents an alkyl, alkoxy or alkenyl group having 2 to 5 carbon atoms.
More preferably, R is selected from any of ethyl, n-propyl, n-butyl, n-pentyl, ethoxy.
As a preferred embodiment of the present invention, Z is1、Z2All represent single bonds.
In a preferred embodiment of the present invention, the fluorine-containing dibenzofuran liquid crystal compound is selected from the structures represented by any one of the following general formulae I-1 to I-11:
Figure BDA0003426766150000022
Figure BDA0003426766150000031
Figure BDA0003426766150000041
wherein, in the general formulas I-1 to I-11, R represents an alkyl group, an alkoxy group or an alkenyl group having 1 to 5 carbon atoms.
Further preferably, in the above general formulae I-1 to I-11, R represents an alkyl group, an alkoxy group or an alkenyl group having 2 to 5 carbon atoms.
More preferably, in the above general formulae I-1 to I-11, R is selected from ethyl, n-propyl, n-butyl, n-pentyl and ethoxy.
As a preferred embodiment of the present invention, the liquid crystal compound is any one selected from the compounds represented by the following structural formulae:
Figure BDA0003426766150000051
Figure BDA0003426766150000061
Figure BDA0003426766150000071
Figure BDA0003426766150000081
Figure BDA0003426766150000091
in a second aspect, the invention provides a preparation method of the cyclopentyl benzofuran liquid crystal compound, which can be synthesized by the following methods according to different substituents in the general formula.
In the first method, when m and n are both 0 in formula (I), the compound has the formula:
Figure BDA0003426766150000092
the synthetic route is as follows:
Figure BDA0003426766150000101
the synthesis method comprises the following steps:
to be provided with
Figure BDA0003426766150000102
Prepared by Suzuki reaction as raw material
Figure BDA0003426766150000103
The above-mentioned
Figure BDA0003426766150000104
Under alkaline conditions, a ring closure reaction is carried out to obtain
Figure BDA0003426766150000105
Wherein, the
Figure BDA0003426766150000106
The reaction molar ratio of (1) to (0.9-1.2) and the reaction temperature of 60-120 ℃; and/or the presence of a gas in the gas,
the above-mentioned
Figure BDA0003426766150000107
The molar ratio of the alkali to the alkali is 1: 1-4, and the reaction temperature is 70-150 ℃; wherein the adopted alkali is any one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and potassium tert-butoxide, and the preferred alkali is potassium tert-butoxide and/or potassium carbonate.
In the second method, when n is 0 and m is not 0 in the formula (I), the synthetic route is as follows:
Figure BDA0003426766150000111
the synthesis method comprises the following steps:
to be provided with
Figure BDA0003426766150000112
Prepared by Suzuki reaction as raw material
Figure BDA0003426766150000113
The above-mentioned
Figure BDA0003426766150000114
Under alkaline conditions, a ring closure reaction is carried out to obtain
Figure BDA0003426766150000115
Wherein,
Figure BDA0003426766150000116
the reaction molar ratio of (1) to (0.9-1.2) and the reaction temperature of 60-120 ℃; and/or the presence of a gas in the gas,
the above-mentioned
Figure BDA0003426766150000117
The molar ratio of the alkali to the alkali is 1 to (1 to up to)4) The reaction temperature is 70-150 ℃; wherein the adopted alkali is any one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and potassium tert-butoxide, and the preferred alkali is potassium tert-butoxide and/or potassium carbonate.
In the third method, when n is 1, m is 0, and Z is2Represents a single bond, A2When represents 1, 4-cyclohexylene, the structural formula is:
Figure BDA0003426766150000121
the synthetic route is as follows:
Figure BDA0003426766150000122
the synthesis method comprises the following steps:
Figure BDA0003426766150000123
with an organolithium reagent and then with
Figure BDA0003426766150000124
Reacting, then dehydrating to obtain
Figure BDA0003426766150000125
The above-mentioned
Figure BDA0003426766150000126
Through hydrogenation reaction, obtain
Figure BDA0003426766150000127
Wherein,
Figure BDA0003426766150000131
an organic lithium reagent,
Figure BDA0003426766150000132
In a molar ratio of1 to (1.0-4.0) to (0.8-1.5), and the reaction temperature is-50 to-100 ℃; the organic lithium reagent is selected from any one or more of sec-butyl lithium, tert-butyl lithium and n-butyl lithium; the dehydrating agent used for dehydration is any one or more of p-toluenesulfonic acid, potassium bisulfate and sodium bisulfate; and/or the catalyst adopted in the hydrogenation reaction is any one or more of palladium carbon, ruthenium carbon and nickel.
In each of the above production methods, R is as defined above.
The liquid crystal compound can be stably and efficiently obtained by the preparation method.
In a third aspect, the invention provides a liquid crystal material composition, wherein the liquid crystal material composition comprises the cyclopentyl benzofuran liquid crystal compound disclosed by the invention. The weight percentage of the cyclopentyl benzofuran liquid crystal compound in the composition is 0.1-60%, preferably 1-40%, and more preferably 2-25%.
In a fourth aspect, the invention provides the application of the cyclopentyl benzofuran liquid crystal compound or the liquid crystal material composition in the liquid phase display field.
As a preferred embodiment, the invention provides the application of the cyclopentyl benzofuran liquid crystal compound or the liquid crystal material composition in a liquid phase display device.
Preferably, the liquid crystal display device includes, but is not limited to, TN, ADS, VA, PSVA, FFS, IPS, and the like liquid crystal displays.
The invention provides a novel liquid crystal compound, in particular to a fluorine-containing cyclopentyl benzofuran liquid crystal compound which has higher negative dielectric anisotropy, good liquid crystal intersolubility, relatively low rotational viscosity and the like, is required by liquid crystal material improvement and has important application value.
The liquid crystal compound or the composition containing the liquid crystal compound has extremely high negative dielectric anisotropy and low rotational viscosity, so that the driving voltage is effectively reduced, the response speed of a liquid crystal display device is improved, and the liquid crystal compound or the composition containing the liquid crystal compound has the advantages of moderate optical anisotropy value, high charge retention rate and the like, and is a liquid crystal material with excellent performance.
Detailed Description
The technical solution of the present invention will be explained in detail below. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
The starting materials are commercially available from the open literature unless otherwise specified.
Example 1
The liquid crystal compound prepared in this example has the structural formula:
Figure BDA0003426766150000141
the synthetic route is as follows:
Figure BDA0003426766150000142
the method comprises the following specific steps:
(1) synthesis of Compound LC-01-1: under the protection of nitrogen, 22g (0.1mol) of 2,3, 4-trifluoro-5-ethoxyphenylboronic acid, 50ml of ethanol, 100ml of toluene, 50ml of water, 13.4g (0.16mol) of sodium bicarbonate and 24g (0.1mol) of 2-hydroxy-3-cyclopentyl-bromobenzene are added into a reaction bottle, the temperature is raised to 50 ℃, 0.01g of dichloro-di-tert-butyl- (4-dimethylaminophenyl) phosphine palladium is added, and the temperature is continuously raised to 70-75 ℃ for refluxing for 2 hours. Work-up after the reaction gave 31.4g of solid in 93.5% yield. The solid LC-01-1 obtained was analyzed by GC-MS and the product had an M/z of 336 (M)+)。
(2) Synthesis of Compound LC-01: under the protection of nitrogen, 30.3g of compound LC-01-1(0.09mol), 200ml of N-N-dimethylformamide and 21g of potassium carbonate (0.15mol) are added into a reaction bottle, the temperature is raised to 110-120 ℃, and the reaction is carried out for more than 4 hours. Work-up after the reaction gave 25.7g of solid in 90.4% yield. The solid LC-01 obtained was analyzed by GC-MS and the product had an M/z of 316 (M)+)。
Example 2
The liquid crystal compound prepared in this example has the structural formula:
Figure BDA0003426766150000143
the synthetic route is as follows:
Figure BDA0003426766150000151
the method comprises the following specific steps:
(1) synthesis of Compound LC-02-1: under the protection of nitrogen, 22g (0.1mol) of 2,3, 4-trifluoro-5-ethoxyphenylboronic acid, 60ml of ethanol, 120ml of toluene, 60ml of water, 22g (0.16mol) of potassium carbonate and 33.2g (0.1mol) of trans-3-cyclopentylcyclohexyl-2-hydroxy-bromobenzene are added into a reaction bottle, the temperature is raised to 50 ℃, 0.01g of dichloro-di-tert-butyl- (4-dimethylaminophenyl) phosphine palladium is added, and the temperature is raised to 70 ℃ to 75 ℃ continuously and refluxed for 2 hours. Work-up after the reaction gave 34.9g of solid in 83.5% yield. The solid LC-02-1 obtained was analyzed by GC-MS and the product had M/z 418 (M)+)。
(2) Synthesis of Compound LC-02: 37.6g of compound LC-02-1(0.09mol), 250ml of N-N-dimethylformamide and 12.4g (0.11mol) of potassium tert-butoxide are added into a reaction flask under the protection of nitrogen, and the reaction is carried out for more than 4 hours at the temperature of 110-120 ℃. Work-up after the reaction gave 31.0g of solid in 86.6% yield. The solid LC-02 obtained was analyzed by GC-MS and the product had an M/z of 398 (M)+)。
Example 3
The liquid crystal compound prepared in this example has the structural formula:
Figure BDA0003426766150000152
the synthetic route is as follows:
Figure BDA0003426766150000153
the method comprises the following specific steps:
(1) synthesis of Compound LC-03-1: under the protection of nitrogen, 22g (0.1mol) of 2,3, 4-trifluoro-5-ethoxyphenylboronic acid, 60ml of ethanol, 120ml of toluene, 60ml of water, 22g (0.16mol) of potassium carbonate and 31.7g (0.1mol) of 4-cyclopentylphenyl-2-hydroxybromobenzene are added into a reaction bottle, the temperature is raised to 50 ℃, 0.01g of dichloro-di-tert-butyl- (4-dimethylaminophenyl) phosphine palladium is added, and the temperature is continuously raised to 70 ℃ to 75 ℃ for refluxing for 2 hours. Work-up after the reaction gave 38.4g of solid in 93.2% yield. The solid LC-03-1 obtained was analyzed by GC-MS and the product had an M/z of 412 (M)+)。
(2) Synthesis of Compound LC-03: 37.1g of compound LC-03-1(0.09mol), 260ml of N-N-dimethylformamide and 12.4g (0.11mol) of potassium tert-butoxide are added into a reaction flask under the protection of nitrogen, and the reaction is carried out for more than 4 hours at the temperature of 110-120 ℃. Work-up after the reaction gave 30.6g of solid in 86.7% yield. The solid LC-03 obtained was analyzed by GC-MS and the M/z of the product was 392 (M)+)。
Example 4
The liquid crystal compound prepared in this example has the structural formula:
Figure BDA0003426766150000161
the synthetic route is as follows:
Figure BDA0003426766150000162
the method comprises the following specific steps:
(1) synthesis of Compound LC-04-1: under the protection of nitrogen, 27.2g (0.10mol) of 2, 3-difluoro-9-cyclopentyl-dibenzofuran and 180ml of tetrahydrofuran are added into a reaction bottle, 0.12mol of n-hexane solution of n-butyllithium is dripped at the temperature of-75 to-85 ℃, the reaction is kept for 2 hours after dripping, 14g (0.10mol) of 4-propylcyclohexyl ketone is dripped at the temperature of-75 to-85 ℃, and then the temperature is naturally returned to-60 ℃ and kept for 2 hours. Adding 200ml of water to quench and react, adding 160ml of toluene, washing with water and separating liquidThen, 5g of p-toluenesulfonic acid is added, reflux water separation is carried out for 6 hours, and conventional post-treatment is carried out to obtain 26.8g of solid, namely a compound LC-04-1, GC: 99.5% and a yield of 68.0%. The solid LC-04-1 obtained was analyzed by GC-MS and the M/z of the product was 394 (M)+)。
(2) Synthesis of Compound LC-04: under the protection of nitrogen, 27.6g of compound LC-04-1(0.07mol), 160ml of toluene, 40ml of ethanol, 2.4g of 5% palladium carbon and 0.5MPa of hydrogen pressure are added into a hydrogenation kettle, the temperature is raised to 40-60 ℃, and the reaction is carried out for more than 4 hours. Work-up of the reaction gave 19.8g of solid in 71.5% yield. The solid LC-04 obtained was analyzed by GC-MS and the product had an M/z of 396 (M)+)。
In the preparation process, the conventional post-treatment is involved if necessary, and the conventional post-treatment specifically comprises the following steps: extracting with dichloromethane, ethyl acetate or toluene, separating, washing with water, drying, evaporating with vacuum rotary evaporator, and purifying the product by vacuum distillation or recrystallization and/or chromatographic separation.
The liquid crystal compounds prepared in examples 1 to 4 of the present invention were subjected to a mixed crystal test as described below. According to the conventional detection method in the field, various performance parameters of the liquid crystal compound are obtained through linear fitting, wherein the specific meanings of the performance parameters are as follows:
S-N represents the crystalline to nematic melting point (. degree. C.) of the liquid crystal;
CP represents the clearing point of the liquid crystal;
Δ n represents optical anisotropy (25 ℃);
Δ ε represents the dielectric anisotropy (25 ℃, 1000 Hz);
γ 1 represents the rotational viscosity (mPa.s, 25 ℃).
The liquid crystal monomers in the following mixed crystal examples can be synthesized by a known method or commercially available.
Mixed crystal example 1
The liquid crystal compound provided in embodiment 1 of the present invention and other liquid crystal monomers are prepared into a mixed crystal composition, and the mixture ratio and the detection results of the components are shown in table 1 below.
The liquid crystal compound of example 1 in table 1 was replaced with comparative compound 1, of the formula:
Figure BDA0003426766150000171
in comparison with the compound 1, which is a compound,
thus obtaining a comparative example, and the proportion and the detection result of the components of the comparative example are shown in the table 2.
TABLE 1
Figure BDA0003426766150000181
TABLE 2
Figure BDA0003426766150000182
Figure BDA0003426766150000191
Mixed crystal example 2
The liquid crystal compound provided by embodiment 3 of the present invention and other liquid crystal monomers are prepared into a mixed crystal composition, and the mixture ratio and the detection results of the components are shown in table 3 below.
The liquid crystal compound of example 3 in table 3 was substituted for comparative compound 2, the structural formula is as follows:
Figure BDA0003426766150000192
the compound of reference 2 was used as a reaction medium,
thus, comparative examples were obtained, and the proportions of the components and the test results of the comparative examples are shown in Table 4.
TABLE 3
Figure BDA0003426766150000193
Figure BDA0003426766150000201
TABLE 4
Figure BDA0003426766150000202
Figure BDA0003426766150000211
Mixed crystal example 3
The liquid crystal compound provided in embodiment 4 of the present invention and other liquid crystal monomers are prepared into a mixed crystal composition, and the mixture ratio and the detection results of the components are shown in table 5 below.
The liquid crystal compound of example 4 in table 5 was replaced with comparative compound 3, of the following structural formula:
Figure BDA0003426766150000212
in comparison with the compound 3, which was a,
thus, comparative examples were obtained, and the proportions of the components and the test results of the comparative examples are shown in Table 6.
TABLE 5
Figure BDA0003426766150000213
Figure BDA0003426766150000221
TABLE 6
Figure BDA0003426766150000222
Figure BDA0003426766150000231
As is apparent from the detection results in tables 1 to 6, when the compound of the present invention is specifically applied to a liquid crystal composition of a conventional system, it is found that the compound can improve the dielectric anisotropy Δ ∈ of the liquid crystal composition, while maintaining a low rotational viscosity γ 1 and a suitable refractive index anisotropy Δ n, and the obtained liquid crystal composition has a significant fast response characteristic and a low voltage driving characteristic.
Although the invention has been described in detail hereinabove by way of general description, specific embodiments and experiments, it will be apparent to those skilled in the art that many modifications and improvements can be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.

Claims (10)

1. A cyclopentyl benzofuran liquid crystal compound having a structure represented by general formula (I):
Figure FDA0003426766140000011
wherein R represents an alkyl group, an alkoxy group or an alkenyl group having 1 to 12 carbon atoms;
A1、A2independently of one another, 1, 4-phenylene, 1, 4-cyclohexylene, 1, 4-cyclohexenylene or fluoro-1, 4-phenylene;
Z1、Z2independently of each other, represents a single bond, a double bond, an oxygen atom, -CF2O-、-CH2CH2-、-CH2O-、-OCH2-or-CH ═ CH-;
m and n independently represent 0, 1 or 2.
2. A compound according to claim 1, wherein m, n independently of each other represent 0 or 1.
3. A compound according to claim 1 or 2, wherein R represents an alkyl, alkoxy or alkenyl group having 1 to 5 carbon atoms.
4. A compound according to any one of claims 1 to 3, wherein Z is1、Z2All represent single bonds.
5. The compound of claim 1, wherein the compound is selected from the structures represented by any one of the following general formulae I-1 to I-11:
Figure FDA0003426766140000012
Figure FDA0003426766140000021
Figure FDA0003426766140000031
wherein, in the general formula, the R represents alkyl, alkoxy or alkenyl with 1-5 carbon atoms;
preferably, said R's each represent an alkyl, alkoxy or alkenyl group having 2 to 5 carbon atoms.
6. The compound of claim 1 or 5, wherein the compound is selected from the group consisting of compounds represented by the following structural formulae:
Figure FDA0003426766140000041
Figure FDA0003426766140000051
Figure FDA0003426766140000061
Figure FDA0003426766140000071
Figure FDA0003426766140000081
7. a process for the preparation of a compound according to claim 1, characterised in that it is synthesized by:
when m and n in the general formula (I) are 0, the compound has the general formula:
Figure FDA0003426766140000082
the synthetic route is as follows:
Figure FDA0003426766140000091
the synthesis method comprises the following steps:
to be provided with
Figure FDA0003426766140000092
And
Figure FDA0003426766140000093
prepared by Suzuki reaction as raw material
Figure FDA0003426766140000094
The above-mentioned
Figure FDA0003426766140000095
Under alkaline conditionsRing closure reaction to obtain
Figure FDA0003426766140000096
Wherein, the
Figure FDA0003426766140000097
And
Figure FDA0003426766140000098
the reaction molar ratio of (1) to (0.9-1.2) and the reaction temperature of 60-120 ℃; and/or the presence of a gas in the gas,
the above-mentioned
Figure FDA0003426766140000099
The molar ratio of the alkali to the alkali is 1: 1-4, and the reaction temperature is 70-150 ℃; wherein the adopted alkali is any one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and potassium tert-butoxide, and the preferred alkali is potassium tert-butoxide and/or potassium carbonate;
when n is 0 and m is not 0 in the general formula (I), the synthetic route is as follows:
Figure FDA0003426766140000101
the synthesis method comprises the following steps:
to be provided with
Figure FDA0003426766140000102
And
Figure FDA0003426766140000103
prepared by Suzuki reaction as raw material
Figure FDA0003426766140000104
The above-mentioned
Figure FDA0003426766140000105
Under alkaline conditions, a ring closure reaction is carried out to obtain
Figure FDA0003426766140000106
Wherein,
Figure FDA0003426766140000107
and
Figure FDA0003426766140000108
the reaction molar ratio of (1) to (0.9-1.2) and the reaction temperature of 60-120 ℃; and/or the presence of a gas in the gas,
the above-mentioned
Figure FDA0003426766140000109
The molar ratio of the alkali to the alkali is 1: 1-4, and the reaction temperature is 70-150 ℃; wherein the adopted alkali is any one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and potassium tert-butoxide, and the preferred alkali is potassium tert-butoxide and/or potassium carbonate;
when n is 1, m is 0, and Z is2Represents a single bond, A2When represents 1, 4-cyclohexylene, the structural formula is:
Figure FDA0003426766140000111
the synthetic route is as follows:
Figure FDA0003426766140000112
the synthesis method comprises the following steps:
Figure FDA0003426766140000113
with an organolithium reagent and then with
Figure FDA0003426766140000114
Reacting, then dehydrating to obtain
Figure FDA0003426766140000115
The above-mentioned
Figure FDA0003426766140000116
Through hydrogenation reaction, obtain
Figure FDA0003426766140000117
Wherein,
Figure FDA0003426766140000118
an organic lithium reagent,
Figure FDA0003426766140000119
The reaction molar ratio of (1) to (1.0-4.0) to (0.8-1.5), and the reaction temperature of-50 to-100 ℃; the organic lithium reagent is selected from any one or more of sec-butyl lithium, tert-butyl lithium and n-butyl lithium; the dehydrating agent used for dehydration is any one or more of p-toluenesulfonic acid, potassium bisulfate and sodium bisulfate; and/or the catalyst adopted in the hydrogenation reaction is any one or more of palladium carbon, ruthenium carbon and nickel.
8. A liquid crystal material composition, comprising the compound according to any one of claims 1 to 6; the mass percentage content of the compound in the liquid crystal material composition is 0.1-60%, preferably 1-40%, and more preferably 2-25%.
9. Use of the compound of any one of claims 1 to 6 or the liquid crystal material composition of claim 8 in the field of liquid crystal display.
10. Use of a compound according to any one of claims 1 to 6 or a liquid crystal material composition according to claim 8 in a liquid crystal display device; preferably, the liquid crystal display device comprises TN, ADS, VA, PSVA, FFS and IPS liquid crystal displays.
CN202111583041.4A 2021-12-22 2021-12-22 Cyclopentyl benzofuran liquid crystal compound and application thereof Active CN114105921B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111583041.4A CN114105921B (en) 2021-12-22 2021-12-22 Cyclopentyl benzofuran liquid crystal compound and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111583041.4A CN114105921B (en) 2021-12-22 2021-12-22 Cyclopentyl benzofuran liquid crystal compound and application thereof

Publications (2)

Publication Number Publication Date
CN114105921A true CN114105921A (en) 2022-03-01
CN114105921B CN114105921B (en) 2024-05-14

Family

ID=80361988

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111583041.4A Active CN114105921B (en) 2021-12-22 2021-12-22 Cyclopentyl benzofuran liquid crystal compound and application thereof

Country Status (1)

Country Link
CN (1) CN114105921B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114805013A (en) * 2022-07-01 2022-07-29 江苏欣诺科催化剂有限公司 Synthesis method of halogenated biaryl compound
CN115895679A (en) * 2022-11-09 2023-04-04 Tcl华星光电技术有限公司 Liquid crystal composition and display panel

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106045953A (en) * 2015-04-13 2016-10-26 默克专利股份有限公司 Fluorinated dibenzofuran and dibenzothiophene derivative
CN106883861A (en) * 2015-12-16 2017-06-23 北京八亿时空液晶科技股份有限公司 A kind of liquid-crystal compounds, composition and its application
CN110300746A (en) * 2017-02-27 2019-10-01 捷恩智株式会社 Compound, liquid-crystal composition and liquid crystal display element with dibenzofurans ring
CN111592517A (en) * 2019-02-20 2020-08-28 北京八亿时空液晶科技股份有限公司 A kind of liquid crystal compound containing dibenzofuran structure and its preparation method and application
US20210098706A1 (en) * 2017-12-18 2021-04-01 Duk San Neolux Co., Ltd. Organic electric element comprising compound for organic electric element and electronic device thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106045953A (en) * 2015-04-13 2016-10-26 默克专利股份有限公司 Fluorinated dibenzofuran and dibenzothiophene derivative
CN106883861A (en) * 2015-12-16 2017-06-23 北京八亿时空液晶科技股份有限公司 A kind of liquid-crystal compounds, composition and its application
CN110300746A (en) * 2017-02-27 2019-10-01 捷恩智株式会社 Compound, liquid-crystal composition and liquid crystal display element with dibenzofurans ring
US20210098706A1 (en) * 2017-12-18 2021-04-01 Duk San Neolux Co., Ltd. Organic electric element comprising compound for organic electric element and electronic device thereof
CN111592517A (en) * 2019-02-20 2020-08-28 北京八亿时空液晶科技股份有限公司 A kind of liquid crystal compound containing dibenzofuran structure and its preparation method and application

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114805013A (en) * 2022-07-01 2022-07-29 江苏欣诺科催化剂有限公司 Synthesis method of halogenated biaryl compound
CN114805013B (en) * 2022-07-01 2022-09-27 江苏欣诺科催化剂有限公司 Synthesis method of halogenated biaryl compound
CN115895679A (en) * 2022-11-09 2023-04-04 Tcl华星光电技术有限公司 Liquid crystal composition and display panel
WO2024099123A1 (en) * 2022-11-09 2024-05-16 惠州华星光电显示有限公司 Liquid crystal composition and display panel

Also Published As

Publication number Publication date
CN114105921B (en) 2024-05-14

Similar Documents

Publication Publication Date Title
CN109206400B (en) Liquid crystal compound containing dibenzothiophene structure and application thereof
CN109207160B (en) A liquid crystal compound with negative dielectric anisotropy and its preparation method and application
CN114105921B (en) Cyclopentyl benzofuran liquid crystal compound and application thereof
CN109423297B (en) Dibenzothiophene liquid crystal compound and preparation method and application thereof
CN111748355B (en) Liquid crystal compound, liquid crystal composition containing liquid crystal compound and liquid crystal display element
CN113913194B (en) Fluorine-containing liquid crystal compound and application thereof
CN114181712B (en) Fluorine-containing liquid crystal compound and application thereof
CN113930246B (en) Liquid crystal compound and application thereof
CN103773384B (en) Liquid crystal compound containing cyclopentyl and pentafluoro-allyloxy and liquid crystal composition thereof
CN106929036A (en) A kind of liquid-crystal compounds and its application containing cyclopenta and trifluoromethyl structure
CN114105966A (en) Liquid crystal compound and preparation method and application thereof
CN114196417B (en) Cyclopentyl-containing liquid crystal compound and application thereof
CN114105919A (en) Liquid crystal compound and preparation method and application thereof
CN113881443A (en) A liquid crystal compound containing dibenzothiophene structure and its application
CN106833676B (en) Cyclopropyl liquid crystal compound and preparation method and application thereof
CN114105941A (en) A new type of liquid crystal compound and its preparation method and application
CN109082281B (en) A liquid crystal compound with negative dielectric anisotropy and its preparation method and application
CN106398717B (en) A kind of epoxypentyl class liquid-crystal compounds and preparation method and application
CN107345141B (en) Liquid crystal compound with negative dielectric anisotropy of isoamyl and application thereof
CN106398716B (en) 4,5- of one kind, bis- fluoro- 7- methyl indans class liquid-crystal compounds and preparation method and application
CN107286950A (en) A kind of cyclopenta liquid-crystal compounds, composition and its application
CN108690636A (en) A kind of liquid-crystal compounds of negative dielectric anisotropic and the preparation method and application thereof
CN113088292A (en) Liquid crystal compound containing phenanthrene structure and preparation method and application thereof
CN111592889B (en) Liquid crystal compound and preparation method and application thereof
CN109423298B (en) A new type of dibenzothiophene liquid crystal compound and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Country or region after: China

Address after: Room 201, Building 11, Building 11, No. 2 Shuangquan Road (Carpet Factory), Dongfeng Street, Yanshan District, Beijing, 102502

Applicant after: Beijing Yunji Technology Co.,Ltd.

Address before: 102500 building 3, building 11, No.2 Shuangquan Road, Dongfeng Street, Yanshan, Fangshan District, Beijing

Applicant before: BEIJING YUNJI TECHNOLOGY CO.,LTD.

Country or region before: China

GR01 Patent grant
GR01 Patent grant